Company: SHPH
Filing Date: 2025-03-25
Form Type: 8-K
Source: 0001641172-25-000595
Chunk: 0

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-03-25
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item
1.01 Entry into a Material Definitive Agreement.

On
March 21, 2025, Shuttle Pharmaceuticals Holdings, Inc. (the “ Company”) entered into a consulting services agreement (the
“ Consulting Agreement”) with Bowery Consulting Group Inc., a corporation registered in the State of Florida (the “ Consultant”).
According to the Consulting Agreement, the Consultant will provide consulting services in connection with the Company’s business,
including conducting research, undertaking due diligence and analysis, and identifying benefits and risks in relation to prospects and
partnership affiliations under consideration, and thereafter advising on viability of plans for scaling activities (and the initiatives)
that support reaching milestones and goals, developing market messaging, growth and capital raising strategies that have the potential
to deliver significant returns and attract investors, and outlining investor and funding strategy for growth (retail and online activity)
and suggesting ways to minimize costs associated with technological platform improvements and marketing spend.

The
Consulting Agreement has a term of six months beginning on March 21, 2025. The Company agreed to pay the Consultant a fee in the amount
of $260,000 for the term of the Consulting Agreement, which will be paid by the Company after it has fully regained compliance with the
Nasdaq Listing Rules.

The
foregoing description of the Consulting Agreement does not purport to be a complete description of the rights and obligations of the
parties thereunder and is qualified in its entirety by reference to the full text of the Consulting Agreement, a copy of which is filed
as Exhibit 10.1 hereto and incorporated herein by reference.

Item
9.01. Financial Statements and Exhibits.

(d)
Exhibits.

  Exhibit No.      Description                                                                                                                         
          1.1      Consulting Agreement, dated March 21, 2025, by and between Shuttle Pharmaceuticals Holdings, Inc. and Bowery Consulting Group Inc.  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover                                                                                                                               

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

  SHUTTLE                                                         
  By:                                 /s/                         
  Name:                               Chris                       
  Title:                              Interim